Neurotoxicity with high-dose disulfiram and vorinostat used for hiv latency reversal

Author(s):

James H. Mcmahon, Vanessa A. Evans, Jillian S.Y. Lau, Jori Symons, Jennifer M. Zerbato, Judy Chang, Ajantha Solomon, Surekha Tennakoon, Ashanti Dantanarayana, Michelle Hagenauer, Sulggi Lee, Sarah Palmer, Katie Fisher, Namandje Bumpus, Carley J.S. Heck, David Burger, Guoxin Wu, Paul Zuck, Bonnie J. Howell, Henrik H. Zetterberg, Kaj Blennow, Magnus Gisslen, Thomas A. Rasmussen, Sharon R. Lewin

Details:

AIDS, Volume 36, Issue 1, 2022-01-01

Article Link: Click here

Affiliations:

• University College London
• University of Melbourne
• The University of Sydney
• University of California, San Francisco
• Johns Hopkins University
• Göteborgs Universitet
• Radboud University Medical Center
• Merck & Co., Inc.
• Sahlgrenska Universitetssjukhuset
• Sahlgrenska Akademin
• UCL Queen Square Institute of Neurology
• Royal Melbourne Hospital
• The Alfred